Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial.

Authors : Retèl VP, Byng D, Linn SC, Koffijberg H, Rutgers EJ, Cardoso F, Piccart-Gebhart M, Poncet C, Vant Veer LJ, van Harten WH
Year : 2020
Journal : Eur J Cancer
Volume : 137
Pages : 193-203